SkinHealth Systems Reports Second Quarter 2026 Financial Results
SkinHealth Systems reported Q2 2026 revenue of $72.1 million, down 7.8% year-over-year, driven by a 19.5% decline in delivery system sales to 770 units. Despite the top-line contraction, Adjusted EBITDA increased 22% to $17.0 million, exceeding guidance, as gross margin expanded 560 basis points to 68.4% and adjusted operating expenses decreased.
Key figures
- Revenue
- 72.1
- Guidance
- FY26 Net sales $280 - $290 million; Adjusted EBITDA $39 - $46 million
- Revenue Yoy
- -7.8%
- Gross margin
- 68.4%
- Adjusted ebitda
- 17
- Active install base
- 36516
- Delivery systems sold
- 770
- Adjusted ebitda margin
- 23.6%
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.